These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 17643088)

  • 1. Angiogenesis in brain tumours.
    Jain RK; di Tomaso E; Duda DG; Loeffler JS; Sorensen AG; Batchelor TT
    Nat Rev Neurosci; 2007 Aug; 8(8):610-22. PubMed ID: 17643088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
    Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme.
    Charalambous C; Chen TC; Hofman FM
    Neurosurg Focus; 2006 Apr; 20(4):E22. PubMed ID: 16709028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization.
    Dieterich LC; Mellberg S; Langenkamp E; Zhang L; Zieba A; Salomäki H; Teichert M; Huang H; Edqvist PH; Kraus T; Augustin HG; Olofsson T; Larsson E; Söderberg O; Molema G; Pontén F; Georgii-Hemming P; Alafuzoff I; Dimberg A
    J Pathol; 2012 Nov; 228(3):378-90. PubMed ID: 22786655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
    Ahir BK; Engelhard HH; Lakka SS
    Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.
    Takano S
    Brain Tumor Pathol; 2012 Apr; 29(2):73-86. PubMed ID: 22218709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic therapy for glioblastoma.
    Gerstner ER; Batchelor TT
    Cancer J; 2012; 18(1):45-50. PubMed ID: 22290257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular targets in angiogenic vessels of glioblastoma tumours.
    Anderson JC; McFarland BC; Gladson CL
    Expert Rev Mol Med; 2008 Aug; 10():e23. PubMed ID: 18684337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of radiotherapy and chemotherapy-targeted therapies in glioblastomas].
    Laigle-Donadey F; Dehais C; Mazeron JJ; Sanson M
    Bull Cancer; 2009 Mar; 96(3):291-7. PubMed ID: 19318307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood Perfusion.
    Cai Y; Wu J; Li Z; Long Q
    PLoS One; 2016; 11(3):e0150296. PubMed ID: 26934465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy.
    de Groot J; Reardon DA; Batchelor TT
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-angiogenic strategies in glioblastoma].
    Guillamo JS
    Rev Neurol (Paris); 2011 Oct; 167(10):662-7. PubMed ID: 21889779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model.
    Hendriksen EM; Span PN; Schuuring J; Peters JP; Sweep FC; van der Kogel AJ; Bussink J
    Microvasc Res; 2009 Mar; 77(2):96-103. PubMed ID: 19118564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
    Hong YK; Chung DS; Joe YA; Yang YJ; Kim KM; Park YS; Yung WK; Kang JK
    Clin Cancer Res; 2000 Aug; 6(8):3354-60. PubMed ID: 10955823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis.
    Giusti I; Delle Monache S; Di Francesco M; Sanità P; D'Ascenzo S; Gravina GL; Festuccia C; Dolo V
    Tumour Biol; 2016 Sep; 37(9):12743-12753. PubMed ID: 27448307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of the vasculature for treatment of cancer and other diseases.
    Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
    Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
    Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
    Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.
    Gerstner ER; Duda DG; di Tomaso E; Ryg PA; Loeffler JS; Sorensen AG; Ivy P; Jain RK; Batchelor TT
    Nat Rev Clin Oncol; 2009 Apr; 6(4):229-36. PubMed ID: 19333229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.